These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16530407)

  • 1. WITHDRAWN: Results of the Two-County trial of mammography screening are not compatible with contemporaneous official Swedish breast cancer statistics.
    Zahl PH; Gøtzsche PC; Andersen JM; Mæhlen J
    Eur J Cancer; 2006 Mar; ():. PubMed ID: 16530407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the Two-County trial of mammography screening are not compatible with contemporaneous official Swedish breast cancer statistics.
    Zahl PH; Gøtzsche PC; Andersen JM; Maehlen J
    Dan Med Bull; 2006 Nov; 53(4):438-40. PubMed ID: 17150148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in endpoints between the Swedish W-E (two county) trial of mammographic screening and the Swedish overview: methodological consequences.
    Holmberg L; Duffy SW; Yen AM; Tabár L; Vitak B; Nyström L; Frisell J
    J Med Screen; 2009; 16(2):73-80. PubMed ID: 19564519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Swedish breast cancer detection results for women aged 40-49.
    Tabar L; Duffy SW; Burhenne LW
    Cancer; 1993 Aug; 72(4 Suppl):1437-48. PubMed ID: 8339236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. A comparison between official statistics and validation by an endpoint committee.
    Nyström L; Larsson LG; Rutqvist LE; Lindgren A; Lindqvist M; Rydén S; Andersson I; Bjurstam N; Fagerberg G; Frisell J
    Acta Oncol; 1995; 34(2):145-52. PubMed ID: 7718250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of mammography screening: updated overview of the Swedish randomised trials.
    Nyström L; Andersson I; Bjurstam N; Frisell J; Nordenskjöld B; Rutqvist LE
    Lancet; 2002 Mar; 359(9310):909-19. PubMed ID: 11918907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study.
    Zackrisson S; Lång K; Rosso A; Johnson K; Dustler M; Förnvik D; Förnvik H; Sartor H; Timberg P; Tingberg A; Andersson I
    Lancet Oncol; 2018 Nov; 19(11):1493-1503. PubMed ID: 30322817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WITHDRAWN: The safety of synthetic paclitaxel by intralesional delivery with OncoGeltrade mark into skin breast cancer metastases: method and results of a clinical pilot trial.
    Rohr UD; Oberhoff C; Markmann S; Gerber B; Scheulen M; Schindler AE
    Arch Gynecol Obstet; 2005 Nov; ():. PubMed ID: 16315026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening.
    Yen AM; Duffy SW; Chen TH; Chen LS; Chiu SY; Fann JC; Wu WY; Su CW; Smith RA; Tabár L
    Cancer; 2012 Dec; 118(23):5728-32. PubMed ID: 22605639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammography screening and breast cancer mortality in Sweden.
    Autier P; Koechlin A; Smans M; Vatten L; Boniol M
    J Natl Cancer Inst; 2012 Jul; 104(14):1080-93. PubMed ID: 22811439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit.
    Tabar L; Fagerberg G; Duffy SW; Day NE
    J Epidemiol Community Health; 1989 Jun; 43(2):107-14. PubMed ID: 2512366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of the Swedish randomised mammography trials: total mortality pattern and the representivity of the study cohorts.
    Nystrom L; Larsson LG; Wall S; Rutqvist LE; Andersson I; Bjurstam N; Fagerberg G; Frisell J; Tabar L
    J Med Screen; 1996; 3(2):85-7. PubMed ID: 8849766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation.
    Duffy SW; Tabar L; Vitak B; Yen MF; Warwick J; Smith RA; Chen HH
    Ann Oncol; 2003 Aug; 14(8):1196-8. PubMed ID: 12881376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent results from the Swedish Two-County Trial: the effects of age, histologic type, and mode of detection on the efficacy of breast cancer screening.
    Tabár L; Chen HH; Fagerberg G; Duffy SW; Smith TC
    J Natl Cancer Inst Monogr; 1997; (22):43-7. PubMed ID: 9709274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammography screening in the county of Fyn. November 1993-December 1999.
    Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
    APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial.
    Tabar L; Fagerberg G; Chen HH; Duffy SW; Smart CR; Gad A; Smith RA
    Cancer; 1995 May; 75(10):2507-17. PubMed ID: 7736395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WITHDRAWN: Performance of survivin mRNA as a biomarker for breast cancer among Vietnamese women.
    Nguyen HM; Dao MQ; La HT
    Breast Dis; 2019 Mar; ():. PubMed ID: 30958326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Swedish randomised mammography screening trials: analysis of their effect on the breast cancer related excess mortality.
    Larsson LG; Nyström L; Wall S; Rutqvist L; Andersson I; Bjurstam N; Fagerberg G; Frisell J; Tabár L
    J Med Screen; 1996; 3(3):129-32. PubMed ID: 8946307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.
    Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH
    APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WITHDRAWN: Downregulation of MicroRNA-152 and Inhibition of Cell Proliferation, Migration, and Invasion in Breast Cancer.
    Maimaitiming A; Wusiman A; Aimudula A; Tudahong T; Aisimutula D
    Oncol Res; 2017 Jun; ():. PubMed ID: 28653610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.